Literature DB >> 15275743

MLC leaf width impact on the clinical dose distribution: a Monte Carlo approach.

Antonio Leal1, Francisco Sánchez-Doblado, Rafael Arráns, Roberto Capote, Juan Ignacio Lagares, Ester Carrasco Pavón, Joan Roselló.   

Abstract

PURPOSE: The influence of the multileaf collimator (MLC) leaf width on the dose distribution in patients treated with conformal radiotherapy and intensity-modulated radiotherapy has been analyzed. This study was based on the Monte Carlo simulation with the beams generated by a linac with the double-focused MLC.
MATERIALS AND METHODS: The transmission through the leaves and the exact shape of the penumbra regions are difficult to model by treatment planning system algorithms. An accurate assessment of the dose variations due to the leaf width change can be achieved by means of Monte Carlo simulation. The BEAM/EGS4 code was used at the Hospital of the Virgen Macarena to model a Siemens PRIMUS linac, featuring an MLC with a leaf width projecting 1 cm at the isocenter. Based on this real model, a virtual head was designed while allowing for a variation of the leaf width projection. Both the real linac and the virtual linac, with leaves projecting 0.5 cm, were used to obtain the dose distributions for several treatments. A few disease sites, including the prostate, head and neck, and endometrium, were selected for the design of the conformal and intensity-modulated radiotherapy treatments with a forward planning algorithm sensitive to the different shapes of the volumes of interest. Isodose curves, differential matrix, gamma function, and the dose-volume histograms (DVHs) corresponding to both MLC models were obtained for all cases. The tumor control probability and the normal tissue complication probability were derived for those cases studied featuring the greatest differences between results for both MLCs.
RESULTS: The impact on the DVHs of changing leaf width projections at the isocenter from 1.0 cm to 0.5 cm was low. Radiobiologic models showed slightly better tumor control probability/normal tissue complication probability values using the virtual MLC with a leaf width projecting 0.5 cm at isocenter in those cases presenting greater differences in the DVHs.
CONCLUSIONS: The impact on the clinical dose distribution due to the MLC leaf width change is low based on the design and conditions used in this study.

Entities:  

Mesh:

Year:  2004        PMID: 15275743     DOI: 10.1016/j.ijrobp.2004.03.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Monte Carlo simulations of electron beams collimated with a dual electron multileaf collimator: a feasibility study.

Authors:  S O Inyang; A C Chamberlain
Journal:  Radiol Phys Technol       Date:  2009-07-04

2.  Dosimetric effect of multileaf collimator leaf width in intensity-modulated radiotherapy delivery techniques for small- and large-volume targets.

Authors:  S A Yoganathan; Karthick Raj Mani; K J Maria Das; Arpita Agarwal; Shaleen Kumar
Journal:  J Med Phys       Date:  2011-04

3.  Impact of Multi-leaf Collimator Parameters on Head and Neck Plan Quality and Delivery: A Comparison between Halcyon™ and Truebeam® Treatment Delivery Systems.

Authors:  Taoran Li; Ryan Scheuermann; Alexander Lin; Boon-Keng Kevin Teo; Wei Zou; Samuel Swisher-McClure; Michelle Alonso-Basanta; John N Lukens; Alireza Fotouhi Ghiam; Chris Kennedy; Michele M Kim; Dimitris Mihailidis; James M Metz; Lei Dong
Journal:  Cureus       Date:  2018-11-28

4.  Dosimetric sensitivity of leaf width on volumetric modulated arc therapy plan quality: an objective approach.

Authors:  Ghulam Murtaza; Muhammad Shamshad; Munir Ahmed; Shahid Mehmood; Ehsan Ullah Khan
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22

5.  Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments.

Authors:  Steffi Kantz; Matthias Söhn; Almut Troeller; Michael Reiner; Helmut Weingandt; Markus Alber; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2015-09-02       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.